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ABSTRACT  
Cytosolic sulfotransferases (SULTs) are enzymes that transfer a sulfuryl group 
from the obligate donor PAPS (3’-phosphoadenosine 5’-phosphosulfate) onto a 
variety of exogenous and endogenous substrates (Negishi 2001). In 2000, a novel 
member of this family (SULT4A1) was isolated from human and rat brain (Falany 
2000). To date, the exact substrate and function of SULT4A1 are not fully 
addressed but since it is highly conserved and expressed extensively, and almost 
exclusively, in the brain, it is possible that SULT4A1 may have an important role in 
the central nervous system. Moreover, some recent reports have associated 
polymorphisms in the SULT4A1 gene with susceptibility to schizophrenia (Brennan 
2005; Meltzer 2008); SULT4A1 has been suggested to be associated with 
neurological symptoms of Phelan-McDermid Syndrome (Disciglio 2014) and 
altered levels of SULT4A1 protein have been observed in bipolar and Alzheimer’s 
patients (Wang 2003; Ryan 2006). 
Given this background, we decided to investigate the still unknown role of 
SULT4A1 within neuron development and functioning. We started evaluating the 
physiological expression of SULT4A1 in the brain areas mainly involved in 
neuropsychiatric and neurodevelopmental disorders. To this purpose, we 
performed western blot analyses of total lysates of hippocampus, striatum, 
cerebral cortex and cerebellum dissected from adult mice (P60). Our results 
showed that SULT4A1 is highly expressed in all the analyzed areas, especially in 
cortex and in cerebellum. Moreover, area-specific expression of SULT4A1 
appears to be similar between adult male and female mice.  
Considering the possible implication of SULT4A1 in the pathogenesis of 
neurodevelopmental disorders, a major point for our study was the evaluation of 
SULT4A1 expression during physiological neuronal maturation. To this purpose, 
we analyzed by western blot rat primary neuronal cultures at different stages of 
neuron maturation, which are Day-In-Vitro (DIV) 1, 7 and 14. From the results of 
these analyses, it was inferable that the expression of SULT4A1 appreciably rises 
during neuronal maturation, going from an almost undetectable level at DIV1 to an 
almost 4-fold greater level at DIV14 in cortical cultures. This result was confirmed 
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by immunofluorescence (IF) staining of the same cultures where the protein 
showed a cytoplasmic localization and its level of expression steadily increased 
from DIV1 to DIV14. IF results also suggested that SULT4A1 is mainly expressed 
in GAD67-positive inhibitory neurons, in particular in Calbindin- and Parvalbumin-
positive neurons.   
Therefore, to better determine SULT4A1 expression in human neurons, we 
obtained peripheral blood mononuclear cells (PBMCs) from control healthy 
individuals and reprogrammed them into induced Pluripotent Stem Cells (iPSCs). 
iPSC-derived neural stem cells (NSC) were differentiated into neurons for at least 
50 days, time necessary to obtain MAP2-positive mature neurons. SULT4A1 
expression was evaluated during neuronal maturation from NSC stage to mature 
neuron and the data from biochemical analysis suggested that the level of 
SULT4A1 protein rises during differentiation of NSCs into neurons.  
Considering that abnormalities in dendritic spines and neuronal arborization are 
some of the most consistent anatomical correlates of neurodevelopmental 
disorders (Hung 2008; Glausier 2013; Jiang 2013; Moyer 2015), we characterized 
the effect of SULT4A1 on spine dynamics and dendrite morphology: in particular, 
we overexpressed or silenced SULT4A1 in cortical cultures and, interestingly, we 
observed that both conditions altered neuronal arborization as well as spine 
density and morphology.  
Moreover, in light of the possibility that SULT4A1 polymorphisms may lead to a 
reduction of mRNA translatability (Brennan 2005) and to clarify the specific role of 
SULT4A1 in neuronal maturation and functioning, we further investigated the 
effects of SULT4A1 silencing. Biochemical and electrophysiological analyses of 
neurons infected or transfected with SULT4A1 shRNA demonstrated that 
SULT4A1 deficiency perturbs the composition and activity of excitatory and 
inhibitory synapses: indeed, we found an increase of GAD65 expression and a 
reduction of GluN1 levels. Interestingly, these data were in line with the 
electrophysiological recordings, where neurons lacking SULT4A1 displayed a 
slight augmentation of spontaneous inhibitory postsynaptic currents (sIPSC) 
frequency and a decrease of spontaneous excitatory postsynaptic currents 
(sEPSC) frequency. 
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ABSTRACT (Ita) 
Le sulfotrasferasi citosoliche (SULTs) sono enzimi che trasferiscono un gruppo 
sulfurilico dal donatore obbligatorio PAPS (3’-fosfoadenosina 5’-fosfosolfato) ad un 
ampio numero di substrati, sia endogeni che esogeni (Negishi 2001). Nel 2000 è 
stato isolato dal tessuto nervoso umano e di ratto un nuovo membro di questa 
famiglia: SULT4A1 (Falany 2000). Ad oggi, l’esatto substrato e la funzione di 
SULT4A1 sono ancora sconosciuti ma, dal momento che è altamente conservata 
ed è espressa quasi esclusivamente nel cervello, è possibile che SULT4A1 rivesta 
un ruolo importante nel sistema nervoso centrale. Inoltre, dei polimorfismi del gene 
SULT4A1 sono stati recentemente associati alla suscettibilità alla schizofrenia 
(Brennan 2005; Meltzer 2008); SULT4A1 è stata anche associata ai sintomi 
neurologici della Sindrome di Phelan-McDermid (Disciglio 2014) e in pazienti 
affetti da bipolarismo e Alzheimer sono stati riscontrati dei livelli alterati della 
proteina SULT4A1 (Wang 2003; Ryan 2006)..  
Noto questo background, abbiamo deciso di chiarire il ruolo di SULT4A1 nello 
sviluppo e nel corretto funzionamento neuronale. Per prima cosa, abbiamo 
valutato l’espressione fisiologica di SULT4A1 nelle aree cerebrali maggiormente 
coinvolte nei disordini neuropsichiatrici e del neurosviluppo: a tal proposito, 
abbiamo effettuato delle analisi biochimiche su lisato totale di ippocampo, striato, 
corteccia cerebrale e cervelletto dissezionati da topi adulti (P60): i nostri risultati 
hanno dimostrato che SULT4A1 è altamente espressa in tutte le aree prese in 
considerazione, specialmente nella corteccia e nel cervelletto. Inoltre, 
l’espressione area-specifica di SULT4A1 sembra essere simile tra topi maschi e 
femmine.  
Considerando il possibile coinvolgimento di SULT4A1 nella patogenesi dei 
disordini del neurosviluppo, un punto focale del nostro studio è la valutazione 
dell’espressione di SULT4A1 durante la maturazione neuronale. A questo scopo, 
abbiamo analizzato via western blot delle colture neuronali embrionali di ratto a 
differenti stadi di maturazione, quali Day-In-Vitro (DIV) 1, 7 e 14. Dai risultati è 
stato possibile dedurre che l’espressione di SULT4A1 aumenta visibilmente 
durante la maturazione dei neuroni corticali, passando da un livello quasi 
impercettibile a DIV1 ad un livello circa quattro volte più alto a DIV14. Questo 
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risultato è stato confermato tramite esperimenti di immunofluorescenza (IF), in cui 
è stato possibile apprezzare la localizzazione citoplasmatica di SULT4A1 e 
l’aumento di espressione passando da DIV1 a DIV14. Dalle analisi di 
immunofluorescenza è stato anche possibile evincere che SULT4A1 è 
maggiormente espressa nei neuroni inibitori GAD67-positivi, in particolare in 
neuroni positivi per Calbindina e Parvalbumina.  
Per conoscere più nel dettaglio l’espressione di SULT4A1 anche in neuroni di 
origine umana, abbiamo ottenuto delle cellule mononucleate del sangue periferico 
(peripheral blood mononuclear cells or PBMCs) da individui sani e le abbiamo 
indotte a cellule staminali pluripotenti indotte (induced Pluripotent Stem Cells  or 
iPSCs). Le cellule staminali neurali (neural stem cells o NSCs) derivate dalle 
iPSCs sono state successivamente differenziate a neuroni per almeno 50 giorni, 
tempo necessario per ottenere neuroni maturi positivi per MAP2. L’espressione di 
SULT4A1 è stata valutata durante la maturazione neuronale dallo stadio di NSC a 
quello di neurone maturo: i dati di biochimica suggeriscono che il livello di 
SULT4A1 aumenta durante il differenziamento da NSC a neurone.  
Dal momento che le alterazioni a livello di spine dendritiche e arborizzazione 
neuronale sono considerate tra i correlati anatomici più validi dei disordini del 
neurosviluppo (Hung 2008; Glausier 2013; Jiang 2013; Moyer 2015), abbiamo 
deciso di focalizzarci questo aspetto della fisiologia neuronale per chiarire il ruolo 
di SULT4A1 nella maturazione e nella funzionalità dei neuroni: in particolare, 
abbiamo overespresso o silenziato SULT4A1 in colture corticali di ratto e abbiamo 
riscontrato che, sorprendentemente, entrambe le condizioni risultano in 
un’alterazione dell’arborizzazione dendritica così come della densità e della 
morfologia delle spine dendritiche. 
Inoltre, alla luce della possibilità che i polimorfismi del gene SULT4A1 possano 
portare ad una riduzione della traduzione di mRNA (Brennan 2005), siamo entrati 
più nel dettaglio nella valutazione degli effetti del silenziamento di SULT4A1. 
Analisi di biochimica e di elettrofisiologia eseguite su neuroni infettati o trasfettati 
con un shRNA specifico per SULT4A1 hanno dimostrato che la mancanza di 
SULT4A1 perturba la composizione e l’attività delle sinapsi sia eccitatorie che 
inibitorie: infatti, abbiamo riscontrato un aumento dell’espressione di GAD65 e una 
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diminuzione dei livelli di GluN1. Dato interessante è che queste variazioni di 
espressione proteica erano in linea con le registrazioni elettrofisiologiche, dal 
momento che i neuroni silenziati hanno mostrato un lieve aumento della frequenza 
delle correnti postsinaptiche inibitorie spontanee (sIPSC) e una diminuzione della 
frequenza delle correnti postsinaptiche eccitatorie spontanee (sEPSC).  
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1. Sulfotransferases 
Sulfotransferases (SULTs) are a superfamily of enzymes that catalyze the reaction 
of sulfonation, also referred to as sulfuryl transfer or sulfation, which consists of 
the transfer of a sulfuryl group (SO3) from the ubiquitous doron 3’-
phosphoadenosine 5‘-phosphosulfate (PAPS) to an acceptor group of numerous 
endogenous and exogenous substrates (Negishi 2001). According to their 
subcellular localization, SULTs can be categorized into two main families: cytosolic 
sulfotransferases and membrane-associated sulfotransferases, which are bound 
to the Golgi apparatus.  
Membrane-associated SULTs sulfonate several compounds such as 
glycosaminoglycans, glycoproteins, peptidyl tyrosine and heparan sulfates, and 
are involved in signaling processes and intercellular communication (Lidholt 1992).  
By contrast, cytosolic sulfotransferases sulfonate steroids, environmental 
chemicals and drugs; in mammals, cytosolic SULTs have been shown to be 
important in the metabolism and excretion of numerous drugs and xenobiotics as 
well as in the homeostasis of endogenous compounds such as steroid and thyroid 
hormones, cholesterol and neurotransmitters (Blanchard 2004; Yasuda 2007). 
Intriguingly, membrane-bound and cytosolic sulfotransferases share little 
sequence similarity and have been reported to have no sequence elements in 
common.  
 
1.1 Cytosolic Sulfotransferases 
Since the late 1980s, a considerable number of cytosolic SULTs have been 
characterized and classified into several gene families according to the similarity of 
their catalytic properties and amino acid sequences (Nagata 2000, Blanchard 
2004; Freimuth 2004): to date, the known SULTs families are SULT1, SULT2, 
SULT4, and SULT6. Even though the family members display considerable 
sequence homology and structural similarity, they are apparently involved in 
different biological processes. The SULT1 family includes nine members which 
form four subfamilies (1A1-4, 1C1-3, 1B1, 1E1): these enzymes catalyze the 
sulfonation of estradiol, simple phenols and thyroid hormones, as well as drugs 
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and xenobiotics. The SULT2 family comprises two genes encoding SULT2A1, 
SULT2B1a, and SULT2B1b proteins which sulfonate steroids like 
allopregnanolone, androsterone and dehydroepiandrosterone (DHEA). Lastly, both 
the SULT4 and SULT6 families comprise a single member encoding an orphan 
enzyme, respectively 4A1 and 6B1, but, out of the two proteins, only SULT4A1 
protein has been characterized (Freimuth 2004). 
 
2. Sulfotransferase 4A1 
Cytosolic Sulfotransferase 4A1 (or BR-STL, brain sulphotransferase-like) was 
isolated from both human and rat brain in 2000 by Falany et al. (Falany 2000). 
Human SULT4A1 gene localizes in the 22q13.1–13.2 region and spans 
approximately 36.5 kb; the 852 bp coding sequence consists of seven exons and 
encodes a 33 kDa protein (Blanchard 2004). The intron between exon 6 and 7 is 
reportedly subject to incorrect splicing, resulting in a second SULT4A1 transcript 
variant which is translated in a truncated protein, unstable in vivo (Sidharthan 
2014).  
SULT4A1 was identified as member of the SULT family on the basis of sequences 
alignment and structure similarities, even though SULT4A1 is one of the human 
SULTs with the lowest sequence homology (<40%) (Minchin 2008). Examining 
SULT4A1 secondary structure (Fig.1) it is possible to appreciate that the cofactor 
binding site involves two different domains of SULT4A1 protein: the N-terminal 
phosphosulfate binding loop, also known as “P-loop”, and a small sequence 
located in the C-terminal region of the protein. The P-loop is responsible for the 
binding to the 5’-phosphate group of PAPS, and is highly conserved in other 
SULTs. The C-terminal domain represents the binding site for 3’-phosphate of the 
cofactor and includes a conserved lysine in a RKG sequence: however, SULT4A1 
protein does not present the lysine residue (Allali-Hassani 2007).   
 
 
Introduction 
11 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. (A) Structural motifs in the SULT4A1 protein, identified by homology with 
other sulfotransferases. (B) Tridimensional structure of human SULT4A1 protein 
showing the central four-stranded parallel β-sheet (yellow) flanked by α-helices 
(red). (modified from Minchin 2008). 
 
SULT4A1 showed a remarkable degree of cross-species similarity: human, mouse 
and rat isoforms share at least 97% amino acid sequence identity, with only nine 
amino acid differences at the protein level. Even human SULT4A1 and Xenopus 
SULT4A1 present a high degree of homology (91% amino acid identity), 
suggesting an important and conserved function across species (Blanchard 2004; 
Minchin 2008).   
Nevertheless, there are some relevant differences in SULT4A1 protein compared 
with other mammalian cytosolic SULTs, in particular at the C-terminus end of the 
sequence. First, a conserved Trp in one of the three α-helices (α3) is replaced with 
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a Leu in SULT4A1; second, a 13-amino-acid gap is present in the PAPS binding 
loop, which also lacks a lysine residue (Lys259, SULT4A1 numbering), key to 
PAPS binding (Allali-Hassani 2007). Taken together, these differences in the 
otherwise highly conserved C-terminal end of SULT4A1 protein might have 
relevant effects on PAPS binding and substrate specificity. Indeed, Allali-Hassani 
et al. showed that SULT4A1 has an atypical crystal structure and its PAPS binding 
pocket, moderately smaller, is proposed to be unable to host the cofactor (Allali-
Hassani 2007); moreover, several potential alternate sulfate donors, such as 4-
methylumbelliferyl sulfate and adenosine phosphosulfate, and different prototypic 
SULT substrates have been tested to asses SULT4A1 catalytic activity but no 
sulfonation activity has been detected with any of these substrates or cofactors, 
suggesting the possibility that SULT4A1 may not have relevant catalytic activity in 
vivo or that the functional enzyme may be active as a part of a multi-enzyme 
complex (Falany 2000).  
 
2.1 Tissue distribution 
SULT4A1 tissue distribution has been examined in both humans and rodents: it 
has been widely demonstrated that it is mainly, but not solely, expressed in the 
brain, albeit the levels of mRNA and protein in other organs such as kidney, lung, 
liver and heart were much less than that in the brain (Alnouti 2006, Sidharthan 
2014). This almost exclusive expression in the brain of different species suggests 
a relevant role for SULT4A1 protein in the central nervous system (CNS). 
Throughout the brain, strongest expression has been detected in cerebral cortex, 
thalamus, cerebellum, and hippocampus (Liyou 2003). Within the cerebral cortex, 
the prefrontal cortex as well as pyramidal neurons of the motor cortex exhibited 
particularly marked immunolabeling; moreover, moderate SULT4A1 expression 
was observed in other areas including insular and cingulated cortex, subthalamic 
nuclei and pituitary gland. 
Sidharthan et al. reported a differential expression of the wild-type transcript and 
the splice variant in numerous tissues and cell-lines (Sidharthan 2014). The 
variant transcript was detected in several tissues such as bladder, cervix and 
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intestine, but not in the brain where, on the contrary, the wild-type transcript was 
highly expressed; similarly, the wild-type transcript was observed only in cell-lines 
derived from neuronal tissue, such as human SH-SY5Y and mouse Neuro 2A 
cells, while the splice variant resulted to be almost ubiquitously expressed. 
Moreover, when human neuroblastoma cell-lines were differentiated into neurons, 
the level of variant transcript remarkably decreased while the expression of wild-
type transcript increased (Sidharthan 2014). Even though SULT4A1 transcript was 
observed in a variety of cell-lines and tissues, the protein was only detected in 
those cells and tissues where the wild-type mRNA was expressed. The switch 
from splice variant to wild-type transcript, followed by the rise in SULT4A1 protein 
expression, may represent a post-transcriptional regulation of SULT4A1 
expression.  
Furthermore, SULT4A1 mRNA expression has been investigated during mouse 
brain development (Alnouti 2006): indeed, mRNA levels were very low in fetal 
brains and remained nearly unchanged until 30 days after birth, when, only in 
female animals, SULT4A1 markedly increased, reaching a fourfold higher 
expression compared to male mice. This diversity may indicate a possible 
hormone responsiveness of SULT4A1 gene. 
 
2.2 Pharmacogenetics and possible relevance to disease 
There are several genetic conditions associated with changes in the structure or 
number of copies of chromosome 22: in particular, the chromosomal region 
around the SULT4A1 gene (22q13) has been implicated in neurodevelopmental 
disorders including schizophrenia and the Phelan-McDermid Syndrome (Brennan 
2005; Disciglio 2014).  
 
2.2.1 Schizophrenia 
Schizophrenia is an enigmatic neuropsychiatric disorder affecting about 1% of the 
world population (Sullivan 2003). There is a wide range of clinical symptoms 
associated with schizophrenia, going from positive symptoms (e.g. delusions and 
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hallucinations), negative symptoms (e.g. anhedonia and social withdrawal), and 
cognitive impairments (e.g. deficits in attention and working memory). 
Schizophrenia has long been known to have a strong genetic component: in fact, 
since no single gene has been found to have a prominent implication in 
schizophrenia etiology, this disease has been included in a group of pathologies 
known as complex genetic disorders (Gejman 2010).  
Recent evidences pointed out a possible role for SULT4A1 gene in genetic 
predisposition to schizophrenia. Brennan and collaborators identified a new 
microsatellite polymorphism in the 5’ untranslated region of SULT4A1 mRNA 
(Brennan 2005). They observed seven alleles of D22s1749E ranging in size from 
198 to 216 nucleotides (nt), among which the 213 and 216 nt alleles appeared to 
be transmitted more often than expected to offspring affected by schizophrenia. 
The 213 and 216 nt alleles are believed to encode mRNA with longer 5’ 
untranslated leader sequences, thus reducing mRNA translatability and final levels 
of SULT4A1 enzyme.  
In 2008, three intronic single nucleotide polymorphisms (SNPs) in SULT4A1 gene 
were proposed to be associated with risk for schizophrenia or schizophrenia 
spectrum disorder (Meltzer 2008): two of these SNPs, rs138060 and rs133097, 
are related, respectively, to clinical symptoms and cognitive function in 
schizophrenia. Furthermore, SULT4A1-1 haplotype status (rs2285162 [A]-
rs2285167 [G]) in schizophrenia patients have been correlated with reduced 
severity of clinical symptoms, superior response to antipsychotic drug olanzapine 
and decreased hospitalization risk in olanzapine-treated patients (Ramsey 2011 
and 2014). Taken together, these evidences suggest that SULT4A1 may represent 
not only a candidate gene for susceptibility to schizophrenia, but also an 
advantageous biomarker to be evaluated prior to initiation of treatment with 
antipsychotic drugs.  
 
2.2.2 Phelan-McDermid Syndrome  
Phelan-McDermid Syndrome (22q13.3 deletion syndrome or PMS) is a genetic 
disease orphan of cure characterized by neonatal hypotonia, global developmental 
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delay, absent to severely delayed speech, intellectual disability, autism and minor 
dysmorphic features (Phelan and McDermid 2012). Although it is widely 
recognized that SHANK3 gene, encoding a scaffold protein of the post-synaptic 
density, is the major gene contributing to the neurological phenotype of PMS 
(Guilmatre 2014; Wang 2014), the wide clinical heterogeneity among PMS 
patients suggests that the haploinsufficiency of genes in the 22q13 region, beside 
SHANK3, might contribute to cognitive and speech development deficits 
associated with PMS: among others, the deletion of SULT4A1 gene has been 
proposed to be related to neurological symptoms of PMS patients (Disciglio 2014). 
 
2.2.3 Other pathologies 
Differential expression of SULT4A1 may indicate a possible correlation of the 
protein with human diseases. For instance, genome wide microarray screens 
revealed that SULT4A1 may be upregulated two- to threefold in brain tissues of 
Alzheimer’s subjects (Wang 2003); by contrast, a downregulation of SULT4A1 
mRNA was observed in the dorsolateral prefrontal cortex of bipolar patients (Ryan 
2006), in intracranial ependymomas (Modena 2006) and in the hippocampus of 
aging rats (Rowe 2007). 
 
2.3 Regulation 
In absence of any substantial catalytic activity, the role of SULT4A1 in the brain is 
yet to be revealed. An attempt towards this issue is represented by the 
identification of interacting proteins involved in SULT4A1 regulation and/or 
function.  
Several authors provided evidences that post-translational modification of 
SULT4A1 can occur in cells, but whether these modifications are essential for 
enzymatic activity is still not known. Butcher et al. identified three cAMP 
responsive elements (CREs) located within the first 100 bp upstream SULT4A1 
transcription star site (Butcher 2010). Two complexes can possibly bind to each 
CRE element in the promoter: the first complex contains CREB homodimers or 
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CREB/ATF-1 heterodimers, while the second complex contains ATF-2/c-Jun 
heterodimers. Even though ubiquitously expressed, both CREB and ATF-2 are 
preferentially expressed in the brain, so their transcriptional regulation of SULT4A1 
may be a key element to understand why the protein is found predominantly in the 
brain.  
Furthermore, SULT4A1 stability can be regulated by events of phosphorylation 
and dephosphorylation. In mouse brain, SULT4A1 can be phosphorylated at Thr8 
and Thr11 (Trinidad 2008), and it has been demonstrated that MAP kinase ERK1 
is responsible for Thr11 phosphorylation (Mitchell 2011); in addition, the 
serine/threonine phosphatase PP2A, which is particularly expressed in the brain, 
is capable of dephosphorylating SULT4A1 through the binding of its regulatory 
subunit Bβ (Mitchell 2011).  
 
2.3.1 The interaction with Pin1 
SULT4A1 phosphorylations at Thr8 and Thr11 are essential for the interaction 
between SULT4A1 and Pin1 (Mitchell 2011). Pin1 is a ubiquitously expressed 
peptidyl-prolyl cis-trans isomerase that binds to phosphorylated serine/threonine-
proline motifs and catalyzes the cis-to-trans isomerization of prolines. It has 
already been shown that Pin1-mediated isomerization can regulate the stability of 
several proteins like p53, c-Myc and c-Jun (Wulf 2001; Yeh 2004): similarly, 
SULT4A1 can undergo Pin1-dependent isomerization through Pin1 interaction with 
the two binding motifs located at SULT4A1 N-terminus. One possible outcome of 
SULT4A1 conformational change is the enhancement of PP2A-mediated 
dephosphorylation and subsequent SULT4A1 degradation via calcium-dependent 
calpains (Mitchell 2009). However, multiple Pin1 sites, like those in SULT4A1 N-
terminus, are supposed to increase Pin1 binding affinity but reduce isomerase 
efficiency (Smet 2005): this implies that SULT4A1 may not be isomerized after 
binding to Pin1, although an isomerization-dependent destabilization of SULT4A1 
has already been demonstrated (Mitchell 2009). Therefore, it is not known whether 
SULT4A1 destabilization is due to Pin1 isomerization or Pin1 isomerase activity is 
directed toward other proteins involved in SULT4A1 degradation.  
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2.4 SULT4A1 deficiency in animal models 
The highly conserved nature of SULT4A1 has allowed the use of zebrafish as a 
model organism to investigate the function of the protein. Indeed, zebrafish and 
human SULT4A1 share considerable sequence homology (87% identity and 92% 
similarity) (Crittenden 2014); moreover, the early development of the nervous 
system in zebrafish larvae provides an excellent opportunity to gain insight into the 
activity of a brain-specific sulfotransferase.  
Falany et al. reported that the morpholino-induced knockdown of SULT4A1 
expression in zebrafish embryos significantly affected a great number of cellular 
pathways, leading to the deregulation of hundreds of genes (Crittenden 2014): 
phototransduction resulted to be the cellular process mainly dysregulated by the 
knockdown, while other processes, including circadian rhythm signaling and CREB 
signaling, were affected to a less extend.  
Further investigations revealed that mutant zebrafish lacking SULT4A1 did not 
present any relevant morphological phenotype but exhibited excessively sedentary 
behaviors during wakefulness (Crittenden 2015). A possible explanation for this 
result is the disruption of the normal sleep cycles in the mutant strain of zebrafish: 
this suggests that SULT4A1 may be involved in the regulation of hypocretin and/or 
melatonin signaling, which are the central pathways in the regulation of sleep and 
wakefulness in diurnal vertebrates like zebrafish.  
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The superfamily of cytosolic sulfotransferases (SULTs) includes enzymes capable 
of transferring a sulfuryl group from the obligate donor PAPS (3’-
phosphoadenosine 5’-phosphosulfate) onto a variety of exogenous and 
endogenous substrates (Negishi 2001). In 2000, a novel member of this family 
(SULT4A1) was isolated from human and rat brain (Falany 2000). Initially termed 
“brain sulfotransferase-like” due to the almost exclusive expression in neuronal 
tissue, it was subsequently renamed SULT4A1 according to sequence homology 
to other cytosolic sulfotransferases (Blanchard 2004). Besides, SULT4A1 is the 
most conserved member of SULT family and it has been identified in all the 
species investigated to date; even species like humans and zebrafish, which do 
not share other homologous SULT genes, present high degree of homology in 
SULT4A1 genes (92% amino acid identity). However, SULT4A1 crystal structure 
suggests that the enzyme may not be able to catalyze the reaction of sulfonation, 
being the active site too small to host the cofactor PAPS (Allali-Hassani 2007). 
Thus, in absence of any known substrate, SULT4A1 biological function remains 
obscure.  
Family transmission disequilibrium analyses have pointed to a possible role for 
SULT4A1 in schizophrenia susceptibility: indeed, specific SNPs and microsatellite 
polymorphisms in SULT4A1 gene appeared to be transmitted more often than 
expected to affected offspring (Brennan 2005) and were related to clinical 
symptoms and cognitive function in schizophrenia patients (Meltzer 2006); 
moreover, SULT4A1-1 haplotype status correlated with severity of clinical 
symptoms, antipsychotic drug response and hospitalization risk (Ramsey 2011 
and 2014). Furthermore, SULT4A1 has been suggested to be associated with 
neurological symptoms of Phelan-McDermid Syndrome (Disciglio 2014) and 
altered levels of SULT4A1 protein have been observed in bipolar and Alzheimer’s 
patients (Wang 2003; Ryan 2006).  
Considering its highly conserved nature and the alterations in its expression 
observed in different physiological and pathological states, it is possible that 
SULT4A1 might have a key function in the central nervous system. Thus, we 
decided to investigate the still unknown role of SULT4A1 within neuron 
development and functioning.  
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We decided to assess its physiological expression, focusing on some of the brain 
areas mainly involved in schizophrenia and autism (i.e. cortex, hippocampus, 
striatum and cerebellum). Given the possible implication of SULT4A1 in the 
pathogenesis of neurodevelopmental disorders a major point for our study was the 
evaluation of SULT4A1 expression during physiological neuronal maturation: to 
this purpose, we used rat primary neuronal cultures as well as human iPSC-
derived neural stem cells in order to gain a more complete picture of SULT4A1 
protein expression in different species.  
Moreover, considering that abnormalities in dendritic spines and neuronal 
arborization are some of the most consistent anatomical correlates of 
neurodevelopmental disorders (Hung 2008; Glausier 2013; Jiang 2013; Moyer 
2015), we characterized the effect of SULT4A1 on spine dynamics and dendrite 
morphology: in particular, we overexpressed or silenced SULT4A1 in cortical 
cultures so to analyze neuronal arborization as well as spine density and 
morphology.  
In light of the possibility that SULT4A1 polymorphisms may lead to a reduction of 
mRNA translatability (Brennan 2005), and to clarify the specific role of SULT4A1 in 
neuronal maturation and functioning we knocked down SULT4A1 in neuronal cells 
using a specific shRNA. Neurons infected or transfected with the SULT4A1 shRNA 
were analyzed by biochemistry and electrophysiology. 
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1. DNA constructs and vectors  
For RNA interference, a siRNA sequence targeting SULT4A1 C-terminal 
(siSULT4A1) was designed following GenScript siRNA Target Finder instructions 
(GenScript) and exhibits the following nucleotide sequence: 
AAGTGTGACCTCACGTTTGAC. The sequence was used to generate a short 
hairpin RNA (shRNA) which was cloned into 2nd generation lentiviral transfer 
vector pLVTHM-GFP (Wiznerowicz and Trono, 2003) with EcoRI and ClaI 
restriction sites (shSULT4A1). A scrambled form of siSULT4A1 was cloned into 
pLVTHM-GFP so to generate the control shRNA (shCtrl).  
pFlag-SULT4A1 previously described (Mitchell 2009) was modified using 
QuikChange Lightning Site-Directed Mutagenesis Kit (Agilent Technologies) to 
generate pFlag-SULT4A1r construct: this construct is resistant to interference by 
siSULT4A1 and was generated by changing three nucleotides of the siSULT4A1 
target site, without changing the amino acid sequence of the resultant protein.  
As control, pLVTHM-GFP vector was used. 
 
2. Animals 
To prepare primary neuronal rat cultures, pregnant female rats (Rattus norvegicus) 
of the phylum Wistar were purchased from Charles River (Charles River 
Laboratories, Calco, Italy). C57BL/6 wild-type mice were purchased from Charles 
River (Charles River Laboratories, Calco, Italy). Mice and rats were housed under 
constant temperature (22 ± 1°C) and humidity (50%) conditions with a 12 h 
light/dark cycle, and were provided with food and water ad libitum. All experiments 
involving animals followed protocols in accordance with the guidelines established 
by the European Communities Council and the Italian Ministry of Health (Rome, 
Italy).  
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3. Primary neuronal culture preparation and transfection 
Low density rat cortical neuronal cultures were prepared from embryonic day (E) 
18 rat embryos (Charles River) as previously described with slight modifications 
(Verpelli 2010). Neurons were plated at high density (350-400 cells/mm2) or 
medium density (150-200 cells/mm²) on 6- or 12-well plates (Euroclone) with or 
without coverslips (VWR), coated with 0.01 mg/ml poly-L-Lysine (Sigma-Aldrich). 
Neurons were cultured in Neurobasal (ThermoFisher) supplemented with home 
made B27 which is a slight variation of a previously described formula (Chen 
2008). 6- and 12-well plates without coverslips were used for protein biochemical 
analysis, whereas 12-well plates with coverslips were used for 
immunocytochemical or electrophysiological analysis. Neurons were transfected 
using Lipofectamine 2000 at day-in-vitro 7 (DIV7), and the experiments were 
performed at DIV14. 
 
4. Lentiviral production and infection of primary rat neuronal cultures 
Genetically modified lentiviruses were produced as previously described (Naldini 
1996; Lois 2002) and the production was carried out with 2nd and 3rd generation 
lentiviral transfer vectors. Lentiviral infection took place at DIV7 and the 
experiments were performed at DIV14. 
 
5. Preparation and neuronal differentiation of human iPS cells 
Human blood samples were collected according to a clinical protocol approved by 
the local Bioethical Committees of different medical centers. Participating 
individuals have been informed of the objectives of the study and have signed an 
informed consent before inclusion in the study. Peripheral blood mononuclear cells 
(PBMCs) were isolated using Ficoll and growth in StemPro®-34 SFM Medium 
(ThermoFisher), supplemented with L-Glutamine (2mM, Euroclone), PenStrep 
(1%, ThermoFisher), SCF (100ng/mL, ThermoFisher), FLT-3 (100ng/mL, 
ThermoFisher), IL-3 (20ng/mL, ThermoFisher), IL-6 (20ng/mL, ThermoFisher). To 
generate induced pluripotent stem cells (iPSCs), PBMCs were transduced with 2.0 
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Sendai virus particles containing four Yamanaka factors using the integration-free 
CytoTune-iPS Sendai Reprogramming Kit (ThermoFisher). After seven days, 
transduced cells were plated on cultures dishes coated with hESC-qualified 
matrigel (Corning) and grown with Essential 8 medium (ThermoFisher). Three to 
four weeks after transduction, iPSC colonies were picked and transferred onto 
matrigel-coated culture dishes (Corning) for further expansion or analysis. 
Immunofluorescence and RT-PCR experiments were performed to detect 
pluripotency markers (Oct 3/4, Lin28, Nanog and Sox2). Then, iPSCs were 
differentiated to neural stem cells (NSCs) via embryoid body method (Verpelli 
2013). To obtain terminally differentiated neurons, proliferating NSCs were plated 
on matrigel-coated 6- or 12-well plates and cultured in Neurobasal medium 
supplemented with B27 w/o vitA (2%, ThermoFisher), PenStrep (1%, 
ThermoFisher), Glutamax (2mM, ThermoFisher), NT-3 (10ng/mL, Miltenyi Biotec), 
BDNF (10ng/mL, Miltenyi Biotec), GDNF (10ng/ml, Miltenyi Biotec), Retinoic Acid 
(1uM, Sigma-Aldrich) and growth for 50 days (Borroni 2017). Medium was 
changed every 2–3 days thereafter.  
 
6. Sample preparation and western blot analysis 
Cells or brain lysates were collected with precooled “buffered sucrose” [0.32 M 
sucrose (Sigma-Aldrich)/4mM HEPES-NaOH buffer (Sigma-Aldrich), pH 7.3, 
protease inhibitors (Roche), phosphatase inhibitors (Roche)] and analyzed via 
Bradford protein assay (Bio-Rad) to assess protein concentration. For total lysate, 
proteins were solubilized in 2-4x loading buffer [(250 mM Tris, 8 % (w/v), 40 % 
(v/v) glycerol, 0.008 % (w/v) bromophenol blue (all Sigma-Aldrich)] in order to have 
a final protein concentration of 1 µg/µl in the sample. In other cases, fractionation 
took place prior to Bradford protein assay analysis to obtain a synaptosome-
enriched fraction (P2) (Huttner 1983; Grabrucker 2011). Also in the case of P2 
fractions, 2-4x loading buffer was added to have a final protein concentration of 1 
µg/µl in the sample. Samples were then heated for 10 min at 95°C; 5-10 µg of 
samples were loaded in the pockets of 7.5-12% polyacrylamide gels (homemade 
with reagents from Bio-Rad) and proteins were electrophoretically separated by 
sodium dodecyl sulfate-Polyacrylamide gel electrophoresis (SDS-PAGE). Then, 
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proteins were electroblotted onto nitrocellulose membranes using the Trans-Blot 
Turbo System (Bio-Rad); membranes were then stained by Ponceau S Stain 
(Sigma-Aldrich) to control the efficiency of protein transfer and were subsequently 
washed twice in Tris-buffered saline-Tween (TBS-T) [20 mM Tris pH 7.4, 150 mM 
NaCl (both Sigma-Aldrich), and 0.1% Tween 20 (Bio-Rad)]. Blocking of 
membranes took place for at least 1.5 h at 4°C in blocking buffer (TBS-T and 5% 
dried nonfat milk). Primary antibodies were applied for 3-16 h in blocking buffer 
(here: with 3 instead of 5% dried nonfat milk); then, HRP-conjugated secondary 
antibodies (Jackson ImmunoResearch Laboratories) were used in blocking buffer 
(3% dried nonfat milk). After each antibody incubation, 3 washes (10 min each) 
took place with TBS-T. Finally, chemiluminescence was induced using an ECL kit 
(GE Healthcare). Immunoblot band intensity was quantified manually with ImageJ 
(US National Institutes of Health), an open source program. Normalization took 
place via actin.  
 
7. Immunocytochemistry 
Cells were fixed in 4% paraformaldehyde and 4% sucrose at room temperature for 
10 minutes and then washed 3 times (10 min for each wash) with PBS [136.8 mM 
NaCl, 2.68 mM KCl, 10.1 mM Na2HPO4 and 1.76 mM KH2PO4, pH 7.4 (all Sigma-
Aldrich)]. Primary antibodies were diluted in homemade gelatin detergent buffer 
(GDB) [30 mM phosphate buffer, pH 7.4, 0.2% gelatin, 0.5% Triton X-100, 0.8 M 
NaCl (all Sigma-Aldrich)] and applied for 3 hours at room temperature or o/n at 
4°C. Secondary antibodies conjugate with fluorophores (Jackson 
ImmunoResearch Laboratories) were also diluted in GDB buffer and applied for 1 
h. After each antibody incubation, 3 washes (10 min each) took place with “high-
salt buffer” [20mM Na2HPO4/NaH2PO4 and 0.5M NaCl, pH 7.4 (all Sigma-Aldrich)] 
and before mounting a final wash (for 10 min) was carried out with PBS. Before 
mounting, coverslips were briefly passed through ddH2O to dilute salts. 4',6-
diamidino-2-phenylindole (DAPI) staining (ThermoFisher) was carried out for 2 min 
(DAPI diluted in PBS to a final concentration of 0.5 μg/ml) and took place during 
the washing steps before mounting the coverslips with Mounting Medium (Vecta 
Shield). 
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8. Section Preparation and Immunohistochemistry  
Animals were anesthetized with an intraperitoneal injection of Avertin (Sigma-
Aldrich) and perfused with 5% sucrose and 4% paraformaldehyde. Then, brains 
were left overnight in 4% paraformaldehyde, followed by incubation in 30% 
sucrose. Finally, brains were included in cryomolds with Tissue-Tek OCT 
compound (Sakura) and put at −80°C until cryostat sectioning. 10μm-thick slices 
were collected on polysine microscope adhesion slides (ThermoFisher) and than 
incubated in blocking solution (3%BSA, 10% goat serum, 0.4% Triton-X-100, 
diluted in PBS). Primary and fluorophore-conjugated secondary antibodies were 
diluted in blocking solution and applied respectively o/n at 4°C and 1h at room 
temperature. After each antibody incubation, 3 washes (10 min each) took place 
with PBS. 4',6-diamidino-2-phenylindole (DAPI) staining (ThermoFisher) was 
carried out for 2 min (DAPI diluted in PBS to a final concentration of 0.5 μg/ml) and 
took place during the washing steps before mounting the coverslips with Mounting 
Medium (Vecta Shield). 
 
9. Antibodies 
The following primary antibodies were used: mouse anti-β-actin (Sigma-Aldrich), 
mouse anti- βIII-tubulin (Sigma-Aldrich), mouse anti-Calbindin D-28K (Swant), 
mouse anti-GABARα1 (NeuroMab),  mouse anti-GAD65 (Synaptic System), 
mouse anti-GAD67 (Santa Cruz Biotechnology), rabbit anti-GluA1 (Millipore), 
mouse anti-GluA2 (NeuroMab), mouse anti-GluN1 (NeuroMab), mouse anti-
GluN2A (NeuroMab), mouse anti-GluN2B (NeuroMab), mouse anti-MAP2 
(Abcam), rabbit anti-mGlu5 (Millipore), mouse anti-Nestin (Millipore), mouse anti-
NL1 (NeuroMab), mouse anti-Oct3/4 (Santa Cruz Biotechnology), goat anti-
Parvalbumin (Swant), mouse anti-Pin1 (Santa Cruz Biotechnology), mouse anti-
PSD-95 (NeuroMab), rabbit anti-Sox2 (Proteintech), rabbit anti-SULT4A1 
(Proteintech), rabbit anti-VGAT (Synaptic System). 
All HRP- and fluorophore-conjugated secondary antibodies were purchased from 
Jackson ImmunoResearch Laboratories.  
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10. Image acquisition and processing 
Confocal images were obtained using LSM 510 Meta confocal microscope (Carl 
Zeiss, a gift from Fondazione Monzino) with Zeiss 63x, 40x or 20x objectives at a 
resolution of 1024 x 1024 pixels. Images represent averaged intensity Z-series 
projections of 5-7 individual images taken at depth intervals of around 0.45 μm. 
Labeled, transfected cells were chosen randomly for quantification from 3 
independent experiments for each condition and image analysis was performed 
under blind condition. 
For dendritic spine analysis, morphometric measurements were performed using 
MetaMorph software (Molecular Devices). Individual dendrites were selected 
randomly and their spines were traced manually. Maximum length and head width 
of each spine were measured and archived automatically.  
For neuronal arborization analyses, primary and secondary dendrites were 
measured manually while Sholl analysis was performed using NeuronStudio 
(Computational Neurobiology and Imaging Center Mountain Sinai School of 
Medicine, New York, NY). Sholl analysis is a method of quantitative analysis used 
in neuronal studies to characterize the morphological features of an imaged 
neuron. It creates a series of concentric circles around the soma of the neuron. 
Within each sphere, various metrics can be obtained such as the total length of 
intersecting dendrites or the number of branching points. We performed Sholl 
analysis to measure the number of branching points in order to evaluate the 
dendritic arborization complexity in adult neurons (DIV14). 
 
11. Electrophysiological recording 
Whole-cell patch-clamp recordings were performed on DIV14 neurons at room 
temperature using a Multiclamp 700A amplifier and pClamp 10.5 software 
(Molecular Devices, Sunnyvale, CA, USA) in voltage-clamp configuration; signals 
were filtered at 1kHz and sampled at 10 kHz. External bath solution contained 
(mM): 129 NaCl, 1.25 NaH2PO4, 35 glucose, 1.8 MgSO4, 1.6 CaCl2, 3 KCl and 10 
HEPES, pH 7.4 with NaOH. Spontaneous excitatory postsynaptic currents 
(sEPSCs) were recorded at -70 mV in the presence of gabazine (12.5 µM) with an 
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internal pipette solution containing (mM): 120 K-gluconate, 15 KCl, 2 MgCl2, 0.2 
EGTA, 10 HEPES, 20 phosphocreatine-tris, 2 ATP-Na2, 0.2 GTP-Na2 and 0.1 
leupeptin, 3 lidocaine N-ethyl bromide, pH 7.2 with KOH. Spontaneous inhibitory 
postsynaptic currents (sIPSCs) were recorded in the presence of kynurenic acid (3 
mM) with an internal pipette solution containing (mM): 135 CsCl, 2 MgCl2, 0.2 
EGTA, 10 HEPES, 20 phosphocreatine-tris, 2 ATP-Na2, 0.2 GTP-Na2 and 0.1 
leupeptin, 3 lidocaine N-ethyl bromide, pH 7.2 with KOH; in these conditions, Cl- 
reversal potential was 0 mV, thus allowing to record at hyperpolarized potentials 
and avoid noise artifacts. The quantification of the instantaneous frequency of 
postsynaptic currents was performed with Clampfit 10.5 and their means and 
cumulative probabilities were analyzed with Origin 8.5 software.  
 
12. Data analysis and display 
Data are expressed as means ± SEM or percentage, were analyzed for statistical 
significance, and were displayed by Prism 5 software (GraphPad, San Diego, CA). 
If there were only two groups whose means were compared, a student’s t-test was 
carried out to assess statistical significance. The accepted level of significance 
was p ≤0.05. In all cases with three or more groups, a one factorial analysis of 
variance (ANOVA) was calculated for the data and if group means differed in a 
significant manner (p ≤0.05), a post hoc Tukey test was calculated to assess 
statistical significance. The accepted level of significance for the post hoc test was 
p ≤ 0.05. Electrophysiology measurements were compared with the Kolmogorov-
Smirnov test, statistical significance level was set at p ≤0.05. 
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1. SULT4A1 is widely and differentially expressed in mouse brain 
In both human and rat, SULT4A1 is expressed throughout the central nervous 
system (CNS) and it appears to have a particularly strong expression in distinct 
areas of the cerebral cortex (e.g. prefrontal cortex), cerebellum (e.g. neuronal 
stroma) and brainstem (e.g. hypoglossal nucleus) (Liyou 2003). In mouse, the 
amount of SULT4A1 mRNA level is remarkably different between male and 
female, given that in female animals the mRNA level appreciably rises after 30 
days after birth (Alnouti 2006). Given these premises, we decided to gain a more 
complete picture of SULT4A1 protein distribution, evaluating the area-specific 
physiological expression as well as potential changes during neuronal 
development. 
We started assessing SULT4A1 protein levels in wild type mouse CNS, focusing 
on the areas mainly involved in neurodevelopmental disorders. To this purpose, 
we performed western blot (WB) analyses of total lysates of hippocampus, 
striatum, cerebral cortex and cerebellum dissected from 2-month-old male mice: 
our results showed that SULT4A1 is highly expressed in all the considered areas, 
especially in cerebral cortex and in cerebellum (Fig.1A). Moreover, the 
immunofluorescent staining of brain sections revealed a localization of SULT4A1 
to neuronal cell bodies and dendrites throughout the cerebral cortex and to 
cerebellar Purkinje cells (Fig. 1C).  
To confirm, at the protein level, the differences between male and female animals 
highlighted by Alnouti et al. (Alnouti 2006), we compared SULT4A1 protein 
expression in male and female mice at post-natal day 60 (P60), age at which 
female animals showed a significantly greater amount of SULT4A1 mRNA 
compared to male mice: however, we did not observe any significant difference in 
protein expression (Fig. 1B).  
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Figure 1. The expression of SULT4A1 was studied in different brain areas of adult 
(P60) wild type mice. (A) Biochemical analysis of total lysates suggested that 
SULT4A1 is differentially expressed in hippocampus (H), striatum (S), cortex (Cx) 
and cerebellum (Cb). All values represent Mean ± SEM of five wild type male mice 
(** p<0.01; *** p<0.001; ANOVA test, Tukey post-test). (B) Area-specific 
expression of SULT4A1 appeared to be similar between adult male (M) and 
female (F) mice. All values represent Mean ± SEM of five wild type male mice and 
five wild type female mice. (C) Staining of mice brain sections revealed SULT4A1 
localization to neuronal cell bodies and dendrites throughout the cerebral cortex 
(left) and to cerebellar Purkinje cells (right).  
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2. SULT4A1 expression rises during neuronal maturation  
Considering that SULT4A1 has been implicated in schizophrenia susceptibility 
(Brennan 2005; Condra 2007; Meltzer 2008) and has been suggested to be 
associated with neurological symptoms of Phelan-McDermid Syndrome (Disciglio 
2014), a major point for our study was the evaluation of SULT4A1 neuronal 
expression during physiological maturation. So, we analyzed by western blot rat 
primary neuronal cultures at different stages of neuron maturation, Day-In-Vitro 
(DIV) 1, 7 and 14. From the results of these analyses, we demonstrated that the 
expression of SULT4A1 substantially rises during neuronal maturation, going from 
an almost undetectable level at DIV1 to an almost 4-fold higher level at DIV14 in 
cortical cultures (Fig. 2A). This result was confirmed by immunofluorescence 
staining of the same cultures where the protein showed a cytoplasmic localization 
and its level of expression steadily increased from DIV1 to DIV14 (Fig. 2B). 
Immunofluorescence results also suggested that SULT4A1 is mainly expressed in 
GAD67-positive inhibitory neurons, in particular in Calbindin- and Parvalbumin-
positive neurons (Fig. 2C). 
 
 
Figure 2. Endogenous levels of SULT4A1 were evaluated in neuronal cultures at 
DIV1, DIV7 and DIV14. (Continues next page) 
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Figure 2. Endogenous levels of SULT4A1 were evaluated in neuronal cultures at 
DIV1, DIV7 and DIV14. (A) The expression of SULT4A1 in total lysates 
appreciably rises during neuronal maturation, going from an almost undetectable 
level at DIV1 to a ~4-fold greater level at DIV14. The gradual development of 
neurons is appreciable through the increase of PSD-95 levels (NeuroMab). All 
values represent Mean ± SEM of five independent experiments (** p<0.01; *** 
p<0.001; ANOVA test, Tukey post-test). (B) Rat cortical neurons at DIV1, DIV7 
and DIV14 were stained with SULT4A1 antibody (ProteinTech) to evaluate 
endogenous levels of the protein. The protein showed a cytoplasmic localization, 
appreciable thanks to the βIII-Tubulin co-staining (Sigma-Aldrich) and its level of 
expression steadily increased from DIV1 to DIV14. (C) Co-staining with GAD67 
(Santa Cruz Biotechnology), Parvalbumin (Swant) and Calbindin D-28K (Swant) 
showed that SULT4A1 is particularly expressed in inhibitory neurons. 
 
 
So far, SULT4A1 protein expression in human neurons has been scarcely 
investigated: in fact, beside the immunohistochemical studies on human brain 
slices performed by Liyou and collaborators (Liyou 2003), only few studies report 
the use of human cell lines (e.g. SK-N-MC) in the characterization of SULT4A1 
regulation and level during neuronal maturation (Mitchell 2009; Sidharthan 2014). 
Therefore, to better determine SULT4A1 expression in human neurons, we 
obtained peripheral blood mononuclear cells (PBMCs) from control healthy 
individuals and reprogrammed them into induced Pluripotent Stem Cells (iPSCs) 
by introducing the four Yamanaka factors (Takahashi 2006). Once tested the 
expression of endogenous pluripotency markers (Oct3/4 and Sox2), iPSCs were 
differentiated into Nestin-positive Neural Stem Cells (NSCs) and subsequently into 
neurons for at least 50 days, time necessary to obtain MAP2-positive mature 
neurons. SULT4A1 expression was evaluated during neuronal maturation from 
NSC stage to mature neuron and the data from biochemical analysis suggested 
that the level of SULT4A1 protein rose during differentiation of NSCs into neurons 
(Fig.3). 
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Figure 3. Peripheral blood mononuclear cells (PBMCs) obtained from control 
healthy individuals were reprogrammed into induced pluripotent stem cells (iPSCs) 
in feeder-free conditions. iPSC-derived neural stem cells (NSCs) were 
differentiated into neurons for at least 50 days, time necessary to obtain MAP2-
positive mature neurons (A). Immunoblots of total lysates of NSCs and 50-day-old 
neurons suggested that the level of SULT4A1 protein rises during differentiation. 
Neuronal differentiation can be appreciated by the increase of PSD-95 and MAP2 
expression (B) All values represent Mean ± SEM of four independent experiments 
(* p<0.05; Student t test). 
 
 
 
 
Results  
36 
 
3. SULT4A1 silencing reduces neuronal branching and dendritic spine 
density 
Regardless its high level of conservation, SULT4A1 substrate and biological 
function remain obscure. Since it has been widely demonstrated that autism 
spectrum disorders and schizophrenia are often associated to alteration in 
neuronal arborization and dendritic spine morphology (Hung 2008; Glausier 2013; 
Jiang 2013; Moyer 2015), we decided to analyze dendritic branching complexity 
and spine density and morphology in cortical neurons overexpressing or lacking 
SULT4A1, so to identify the possible neuronal function of SULT4A1.   
First, we generated a shRNA specific for SULT4A1 with the aim of examining the 
effect SULT4A1 knockdown in neuronal cultures. Briefly, rat cortical neurons were 
transfected at DIV7 with SULT4A1-specific shRNA (shSULT4A1) or control 
scrambled shRNA (shCtrl), and then fixed at DIV14 (Fig.4A). Dendrites 
quantification and Sholl analysis revealed that SULT4A1 depletion resulted in a 
simplification of neuronal branching, suggested by the reduction of the number of 
branching points, primary and secondary dendrites (Fig.4B). This phenotype was 
rescued by the overexpression of SULT4A1r, a construct resistant to interference 
by SULT4A1-specific shRNA (Fig.4).  
SULT4A1 knockdown had also a remarkable effect on dendritic spine density; 
indeed, spines derived from neurons lacking SULT4A1 showed normal length and 
width but the number of those spines per 10 µm was significantly decreased. Once 
again, the resistant construct was able to revert the alteration of spine density 
(Fig.5).   
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Figure 4. Confocal microscopy images showing neuronal morphology of rat 
cortical neurons transfected at DIV7 with a plasmid expressing shCtrl, shSULT4A1 
or GFP and SULT4A1r (A). The quantification and distribution of number of 
branching points, primary and secondary dendrites revealed that SULT4A1 
depletion led to a simplification of neuronal branching (B). All values represent 
Mean ± SEM (*shSULT4A1 vs shCtrl, * p<0.05, ** p<0.01, *** p<0.001; # 
shSULT4A1 vs SULT4A1r, ## p<0.01, ### p>0.001; Student t test). At least 10 
neurons per each condition from three independent experiments were analyzed. 
Scale bar= 10 μm 
 
 
 
Figure 5.  Immunofluorescence images showing dendritic spines of rat cortical 
neurons transfected at DIV7 with shCtrl, shSULT4A1 or GFP and SULT4A1r (A). 
Spines derived from neurons lacking SULT4A1 showed normal length and width 
but the number of those spines per 10 μm was significantly decreased (B). All 
values represent Mean ± SEM (*shSULT4A1 vs shCtrl, * p<0.05; # shSULT4A1 vs 
SULT4A1r, # p<0.05; Student t test). At least 10 neurons per each condition from 
three independent experiments were analyzed. Scale bar= 10 μm 
 
Results  
39 
 
4. SULT4A1 overexpression impairs dendritic arborization and spines  
To assess the effect of SULT4A1 overexpression, cortical neuronal cultures were 
transfected at DIV7 with GFP or GFP and SULT4A1 and were fixed and stained at 
DIV14 with anti SULT4A1 antibody, in order to locate SULT4A1-overexpressing 
neurons. The analysis of confocal microscopy images revealed that SULT4A1 
overexpression led to an overall increase of the number of branching points, which 
appeared to have a different organization along the dendritic tree compared to wild 
type neurons: in fact, neuron overexpressing SULT4A1 presented a decreased 
number of branching points close to the soma (<50 μm from soma) and an 
increased number of distal branching points (>100 μm from soma) (Fig.6), 
suggesting a reorganization of neuronal arborization. However, the number of 
primary and secondary dendrites was apparently equal between the two 
conditions.  
Moreover, cortical neurons overexpressing SULT4A1 displayed a slightly 
decreased density of dendritic spines, which were also considerably longer than 
wild type spines (Fig.7).  
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Figure 6. Confocal microscopy images showing neuronal branching of rat cortical 
neurons transfected at DIV7 with a plasmid expressing GFP or GFP and SULT4A1 
(A). Sholl analysis revealed that SULT4A1 overexpression (OV) led to a 
reorganization of neuronal branching, with an overall increase of the number of 
branching points (B). All values represent Mean ± SEM (* p<0.05, ** p<0.01, *** 
p<0.001, Student t test). At least 10 neurons per each condition from three 
independent experiments were analyzed. Scale bar= 10 μm 
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Figure 7.  Microscopy images showing dendritic spines of rat cortical neurons 
transfected at DIV7 with GFP or GFP and SULT4A1 (A). Spines derived from 
neurons overexpressing SULT4A1 (OV) showed increased length and decreased 
density (B). All values represent Mean ± SEM (* p<0.05; ** p<0.01, Student t test). 
At least 10 neurons per each condition from three independent experiments were 
analyzed. Scale bar= 10 μm 
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5. SULT4A1 knockdown alters synaptic transmission 
Several authors speculate that polymorphisms of SULT4A1 gene may be related 
to cognitive deficits and clinical symptoms in schizophrenia or schizophrenia 
spectrum disorder. For instance, the microsatellite polymorphism in the 5’ end of 
SULT4A1 gene described by Brennan and collaborators, is believed to reduce its 
mRNA translatability and result in lower final levels of SULT4A1 enzyme (Brennan 
2005).  
For this reason, despite the intriguing results obtained through the overexpression 
of SULT4A1, we decided to focus on the characterization of SULT4A1 knockdown.   
Based on the alterations of dendritic arborization and spine density, we examined 
the effect of SULT4A1 silencing on the level of relevant synaptic proteins, 
considering both excitatory and inhibitory synapses. The screening of total lysates 
of rat cortical neurons infected with shCtrl or shSULT4A1 revealed that SULT4A1 
knockdown led to a significant increase of GAD65 protein level and, 
simultaneously, to a decrease of GluN1 amount (Fig.8). These data suggested 
that the presence of SULT4A1 might somehow influence both excitatory and 
inhibitory synaptic transmission.  
A similar result was obtained when spontaneous post-synaptic currents were 
recorded from the same cultures: indeed, neurons lacking SULT4A1 displayed an 
appreciable reduction of spontaneous excitatory postsynaptic currents (sEPSC) 
frequency, reflected by the leftward shift of the curve in the cumulative probability 
plot, and to a slight augmentation of spontaneous inhibitory postsynaptic currents 
(sIPSC) frequency, reflected by the rightward shift of the curve in the range of 0.5-
5 Hz (Fig.9).   
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Figure 8. The reduction of SULT4A1 expression following silencing was evaluated 
via biochemical analysis of lysates of cortical neurons infected with lentivirus 
expressing shCtrl or shSULT4A1. Both shCtrl (grey) and shSULT4A1 (black) 
conditions were compared with non-infected condition (Ni) so to verify whether the 
infection itself caused any alteration of SULT4A1 protein expression (A). The 
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knockdown of SULT4A1 led to a significant increase of GAD65 expression and a 
decrease of the levels of NMDAR subunit GluN1 (B). All values represent Mean ± 
SEM of four independent experiments (* shSULT4A1 vs Ni or shCtrl, *p<0.05, *** 
p<0.001, Student t test). 
 
 
 
Figure 9. Analysis of spontaneous postsynaptic currents. (A) Representative 
sEPSCs recorded from shCtrl (grey) or shSULT4A1 (black) transfected neurons. 
(B) Cumulative probability plot showing a significant decrease in sEPSCs 
frequency when SULT4A1 is silenced (Kolmogorov-Smirnov test, * p<0.05). Inset 
panel shows EPSCs mean instantaneous frequency. (C) Representative sIPSCs 
recorded from shCtrl (grey) or shSULT4A1 (black) transfected neurons. (D) 
Cumulative probability plot showing a small but significant increase in sIPSCs 
frequency when SULT4A1 is silenced (Kolmogorov-Smirnov test, * p<0.05). Inset 
panel shows sIPSCs mean instantaneous frequency. At least five neurons per 
each condition from three independent experiments were analyzed. 
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6. The interaction with Pin1 might be the key to unveil SULT4A1 role in 
excitatory synapses 
Peptidyl-prolyl cis-trans isomerase Pin1 is known to be recruited to excitatory 
synapses, where it exerts a negative action on synaptic transmission by 
suppressing protein synthesis and impeding the organization of crucial structural 
protein complexes (Westmark 2010). In particular, Antonelli and collaborators 
have demonstrated that Pin1 negatively affects NMDAR signaling and spine 
morphology by dampening PSD-95 ability to complex with the glutamate receptor 
subunits GluN1 and GluN2B (Antonelli 2016).  
Mitchell and Minchin have proven that SULT4A1 is able to recruit Pin1 at the 
phosphoserine/threonine-proline motifs in its N-terminus, meaning that, potentially, 
SULT4A1 can be post-translationally modified (Mitchell 2009). However, multiple 
Pin1 sites, like those in SULT4A1 N-terminus, reportedly increase Pin1 binding 
affinity but reduce isomerase efficiency (Smet 2005), and this implies that 
SULT4A1 may not be isomerized after binding to Pin1.  
Considering our data on the reduction of both GluN1 protein level and sEPSC 
frequency following SULT4A1 depletion, and the Pin1-driven modulation of 
synaptic transmission and dendritic spine dynamics proposed by Antonelli et al., 
we verified whether there was any detectable difference in the synaptic amount of 
Pin1, PSD-95 and NMDAR subunits in presence or absence of SULT4A1 
expression. Interestingly, immunoblot analysis revealed that the synaptosomal 
preparations derived from SULT4A1-deficient neurons exhibited increased levels 
of Pin1, significantly lower levels of GluN1 and a reduction of GluN2B and PSD-
95, albeit not statistically significant (Fig.10). 
This observation prompted us to hypothesize that the binding of SULT4A1 to Pin1 
somehow prevents Pin1 from exerting its negative effect on PSD-95/NMDAR 
complex formation, plausibly by binding to and seizing Pin1 or by operating as a 
substrate, alternative to PSD-95, for Pin1 isomerase activity.   
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Figure 10. Representative immunoblots of synaptosome fractions obtained from 
neuronal cultures infected with shCtrl (grey) or shSULT4A1 (black). SULT4A1 
silencing resulted in reduced synaptic level of GluN1 and increased level of Pin1. 
GluN2B synaptic level appeared to be reduced, even though the reduction was not 
significant (p=0.0883). All values represent Mean ± SEM of three independent 
experiments (*p<0.05, ** p<0.01, *** p<0.001, Student t test).  
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Cytosolic sulfotransferases are a superfamily of enzymes that transfer a sulfuryl 
group to a wide range of endogenous and exogenous substrates; SULT4A1 is the 
newest member of this family. Since its identification in 2000 by Falany and 
collaborators (Falany 2000), SULT4A1 has presented an enigma in the field of 
cytosolic SULT biology: indeed, its biological function is yet to be revealed, mainly 
because several previous studies have failed to identify possible SULT4A1 
substrates (Allali-Hassani 2007). However, given that it is highly conserved and 
expressed extensively, and almost exclusively, in the brain, it is possible that 
SULT4A1 may have a role in the central nervous system (Liyou 2003; Alnouti 
2006). Moreover, some recent reports have associated polymorphisms in the 
SULT4A1 gene with susceptibility to schizophrenia (Brennan 2005; Meltzer 2006) 
and haploinsufficiency of SULT4A1 has been suggested also to be associated with 
neurological symptoms of Phelan-McDermid Syndrome (Disciglio 2014); 
additionally, altered levels of SULT4A1 protein have been observed in bipolar and 
Alzheimer’s patients (Wang 2003; Ryan 2006).  
Given this background, we decided to investigate the still unknown role of 
SULT4A1 within neuron development and functioning.  
First, we decided to evaluate SULT4A1 tissue distribution in adult mouse brain, 
being the current knowledge of SULT4A1 area-specific expression restricted to 
human and rat tissues (Liyou 2003): immunoblots and fluorescence 
immunohistochemistry analyses confirmed that, even in mice, SULT4A1 is 
abundantly present in areas mainly associated with neuropsychiatric disorders, 
such as hippocampus, striatum, cerebral cortex and cerebellum. In particular, high 
levels of SULT4A1 were observed in cortical neurons and in cerebellar Purkinje 
cells (Fig.1A-C). We tested if SULT4A1 protein was differentially expressed 
between male and female brains but, in contrast to the data reported by Alnouti 
and collaborators (Alnouti 2006) we did not detect any significant difference.  We 
only found a slightly, but not significantly, greater amount of SULT4A1 protein in 
female cortex, compared to male animals of the same age (Fig.1-B). This 
discrepancy might be due to the fact that we analyzed separately four distinct 
brain areas, whereas previously reported mRNA quantifications were performed 
on total mRNA isolated from the whole mouse brain.   
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Once elucidated its tissue distribution, a major point for deciphering SULT4A1 
physiological function is the characterization of the enzyme expression during 
neuronal maturation.  
To this purpose, we assessed SULT4A1 level during neuronal maturation in both 
rodent and human neuronal cultures: we started analyzing rat primary cortical 
cultures at different stages of maturation (i.e. DIV1, DIV7 and DIV14) (Fig.2A-B), 
then we differentiated human iPSC-derived neural stem cells (NSCs) into mature 
neurons and collected total lysates before and after neuronal differentiation (Fig.3). 
In line with previous observations regarding the increasing expression of SULT4A1 
during neuronal maturation (Sidharthan 2014), we found that in both human and 
rodent neuronal cultures, SULT4A1 level rises during maturation and 
differentiation, suggesting an important role of this protein throughout CNS 
development.   
While assessing SULT4A1 localization via immunostaining of rat cortical neurons, 
we noticed that some neurons were intensely labeled when stained with the 
antibody against SULT4A1: subsequent co-labeling assays revealed that the 
highly-positive cells were inhibitory, GAD67-positive neurons and more specifically 
Parvalbumin-positive and Calbindin-positive neurons (Fig.2C). This result provides 
an important clue for further investigation considering that, in the last few years, 
gabaergic circuitry disruption has been widely proposed to be an important player 
in the pathogenesis of schizophrenia and neurodevelopmental disorders (Pizzarelli 
2011; Chattopadhyaya 2012; Nakazawa 2012).  
The study of sequence homology and gene expression patterns can provide leads 
about gene function, but they do not reveal what is the exact physiological role of a 
gene. From this perspective, a powerful tool is represented by genetic engineering 
techniques which allow to modulate protein expression: few examples are gene 
overexpression, leading to abnormally high levels of gene expression (Prelich 
2012), and gene silencing, achievable by RNA interference (RNAi)-based 
methodologies (Bantounas 2004).  
Therefore, with the purpose of gaining insights into the activity of SULT4A1 gene, 
we verified how overexpression and silencing of SULT4A1 might affect 
phenotypes in neuronal cultures. Since it is widely acknowledged that 
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schizophrenia and autism spectrum disorders are often correlated to deficiencies 
in dendrites architecture and spine dynamics (Hung 2008; Glausier 2013; Jiang 
2013; Moyer 2015), we started evaluating neuronal branching complexity and 
dendritic spine density and morphology in cortical neurons overexpressing or 
lacking SULT4A1. 
Interestingly, both conditions altered neuronal physiology. Regarding neuronal 
arborization, we found a decrease in the number of branching points in absence of 
SULT4A1 (Fig.4), and, conversely, an increase of branching points number in 
neurons overexpressing SULT4A1, which also displayed a reorganization of 
branching points distribution along the dendritic tree (Fig.6).  
Dendritic spines emerged to be influenced by SULT4A1 levels too: in fact, 
SULT4A1 knockdown affected spine density but without altering their morphology 
(Fig.5); on the other hand, SULT4A1 overexpression had a greater effect on spine 
morphology rather than on spine density, leading to a significant increase in spine 
length and a slight decrease in spine density (Fig.7). These observations suggest 
that the expression of SULT4A1 at the appropriate level is crucial to ensure proper 
neuronal development and functioning, seeing as the outcome of SULT4A1 
expression below and above some critical threshold is a remarkable defect in both 
neuronal arborization and dendritic spines.  
In the light of the possibility that SULT4A1 polymorphisms, identified in 
schizophrenia patients, may lead to a reduction of mRNA translatability (Brennan 
2005), we further investigated the effects of SULT4A1 silencing, despite the 
intriguing results obtained through SULT4A1 overexpression.  
Biochemical and electrophysiological analyses of cortical neurons knockdown for 
SULT4A1 showed that SULT4A1 deficiency perturbs the composition and activity 
of excitatory and inhibitory synapses. Immunoblotting for relevant excitatory and 
inhibitory markers unveiled an increase of GAD65 expression and a decrease of 
GluN1 levels in shSULT4A1-infected cortical neurons (Fig.8). Interestingly these 
data were in line with the electrophysiological recordings, where neurons lacking 
SULT4A1 displayed a slight increase in sIPSC frequency and a reduction of 
sEPSC frequency (Fig.9).  
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NMDA receptors mediate spine formation, maturation and stabilization via 
calcium-dependent signaling (Matus 2000): in particular, NMDAR-mediated 
calcium influx into dendritic spines induces forms of synaptic plasticity, such as 
long-term potentiation (LTP) and long-term depression (LTD) (Nagerl 2004; Tada 
2006; Ultanir 2007). Given that proper expression and regulation of NMDARs is 
crucial for neuronal plasticity and maturation as well as learning and memory 
processes (Snyder 2013), it is not surprising that several authors have 
hypothesized a link between disrupted NMDAR function and developmental and 
psychiatric disorders: indeed, a large number of clinical and animal studies 
converge to the “NMDARs hypofunction hypothesis” as the possible root cause of 
diseases such as schizophrenia and autism spectrum disorders (Coyle 2012; Lee 
2015).  
A possible connection between SULT4A1 and NMDARs could be represented by 
the Peptidyl-prolyl cis-trans isomerase Pin1. The interaction between SULT4A1 
and Pin1 has been demonstrated by Mitchell and collaborators (Mitchell 2009) but 
it is not clear whether this interaction implies SULT4A1 isomerization, being the 
multiple Pin1 sites in SULT4A1 N-terminus reportedly able to increase Pin1 
binding affinity but reduce isomerase efficiency (Smet 2005).  
Antonelli et al. demonstrated that Pin1 can be recruited to excitatory synapse by 
its binding to PSD-95: once isomerized, PSD-95 ability to complex with NMDAR 
subunits GluN1 and GluN2B is drastically reduced, thus affecting NMDA-mediated 
transmission and spine morphology (Antonelli 2016). Moreover, pyramidal neurons 
derived from Pin1-/- mice exhibits increased spine density and increased amount 
of GluN1 and GluN2B. These features resulted to be practically opposite to the 
phenotype described in SULT4A1 knockdown experiments. 
Thus, this observation prompted us to hypothesize that the interaction with Pin1 
might be the key to unveil SULT4A1 role in excitatory synapses. According to our 
hypothesis, SULT4A1 represents an alternate partner or substrate for Pin1, 
whether in neuronal soma or at a synaptic level. In absence of SULT4A1, a higher 
amount of Pin1 can be recruited to dendritic spines, where it exerts its negative 
effect on PSD-95/NMDAR complex formation. This hypothesis is also supported 
by the evidence that synaptosomal preparations derived from neurons infected 
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with shSULT4A1 presented increased amount of Pin1 and decreased content of 
GluN1, GluN2B and PSD-95 (Fig.10), suggesting a feasible major recruitment of 
Pin1 to the synapse in the absence of SULT4A1.  
Validating this hypothesis requires a set of key experiments, which are currently in 
progress: first, a co-immunoprecipitation should be performed to demonstrate that 
SULT4A1 presence can interfere with Pin1/PSD-95 interaction; simultaneously, it 
is essential to assess NMDA-mediated currents in control and silenced conditions, 
so to have a functional match on NMDAR subunits decrease. Finally, the 
hypothesis of Pin1-based activity of SULT4A1 may offer the opportunity for a 
pharmacological rescue of the phenotypes caused by SULT4A1 depletion: indeed, 
Pin1 selective inhibitors are available and, among them, PiB (Millipore) has 
already been exploited to block Pin1 isomerase activity and modulate PSD-
95/NMDAR complex formation (Antonelli 2016). 
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